Spotlight on PSMA as a new theranostic biomarker for bladder cancer

Bladder cancer (BCa) patients are diagnosed by cytology and cystoscopy. However, these diagnostic tests bear some limitations. We sought for reliable biomarkers to better determine BCa extension. Prostate-specific membrane antigen (PSMA) appears to fulfill this requirement in prostate cancer but its...

Descripción completa

Detalles Bibliográficos
Autores principales: Tumedei, Maria Maddalena, Ravaioli, Sara, Matteucci, Federica, Celli, Monica, De Giorgi, Ugo, Gunelli, Roberta, Puccetti, Maurizio, Paganelli, Giovanni, Bravaccini, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105396/
https://www.ncbi.nlm.nih.gov/pubmed/33963223
http://dx.doi.org/10.1038/s41598-021-89160-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105396/
https://www.ncbi.nlm.nih.gov/pubmed/33963223
http://dx.doi.org/10.1038/s41598-021-89160-0

Ejemplares similares